Firm News

Home 9 News Item 9 Wiggin and Dana Advises EndoQuest Robotics on Series D-2 Funding Round

Wiggin and Dana Advises EndoQuest Robotics on Series D-2 Funding Round

July 14, 2025

Wiggin and Dana recently represented EndoQuest Robotics, a leader in endoluminal robotic surgical technology, in its Series D-2 Funding Round. This funding was co-led by Crescent Enterprises and Dr. Fred Moll. Other investors included Puma Venture Capital and The University of Texas Health Science Center at Houston (UTHealth Houston).

The Wiggin deal team consisted of Evan Kipperman, R.J. Kornhaas, and Jordan Yellen.

To learn more, click here.

 

Resources

Firm Highlights